);
Contact

News

Posted on
LinkedIn Post 1
May 2021

We have been noticed by Foreign Affairs Belgium!

In vitro fertilization (IVF) can help women unable to naturally conceive to have a child. However, even if this expensive treatment is successful right away, it is still arduous for the couple. New technology developed by Fertiga ensures an enhanced success rate and increased comfort, while also highlighting Belgium’s position as a leader in the field of fertility research.

From a medical and health standpoint, the benefits are considerable, resulting in less physical and mental strain for the parents, saving them both time and money.

Posted on
LinkedIn Post 1
February 2021

We have been published in Reproductive Biology and Endocrinology!

Non-invasive oocyte quality scoring, based on cumulus gene expression analysis, in combination with morphology scoring, can increase the clinical pregnancy (CPR) and live birth rates (LBR) in Day 3 eSET (elective single embryo transfer) ICSI patients. This was first investigated in a pilot study and is now confirmed in a large patient cohort of 633 patients. It was investigated whether CPR, LBR and time-to-pregnancy could be improved by analyzing the gene expression profile of three predictive genes in the cumulus cells, compared to patients with morphology-based embryo selection only.

đź’ˇThe results of our study proved that:

  • the clinical pregnancy rate (CPR) was 61% in the Aurora test arm (n = 113) compared to 29% in the control arm (n = 520,  p < 0.0001).
  • the live birth rate (LBR) in the Aurora test arm (50%) was significantly higher than in the control arm (27%, p < 0.0001).
  • the time-to-pregnancy was significantly shortened by 3 transfer cycles independent of the number of embryos available on Day 3 (Kaplan-Meier, p < 0.0001).

EN
EN